Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity

Dae Hyun Baek, Su Yeon An, Jae Hyun Park, Youngju Choi, Ki Dae Park, Jin Wook Kang, Kyoung Suk Choi, Sung Hee Park, Min Young Whang, Jiyou Han, Jong-Hoon Kim, Hyung Soo Kim, Dongho Geum, Tae Moo Yoo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We developed and analyzed a new surrogate endpoint of the mouse embryonic stem cell test (EST) for developmental neurotoxicity. To determine the sensitivity, specificity, and transferability of the new endpoint, a pre-validation team from three independent laboratories optimized and standardized the protocol for neuronal differentiation of mouse embryonic stem cells (mESCs) by measuring the neuronal differentiation rates of mESCs under different culture conditions, such as the presence or absence of basic fibroblast growth factor (bFGF) in the growth media and varying lengths of culture. In addition, a component ratio of neuronal cells was measured by using flow cytometry analysis of β-III tubulin (Tuj1)-positive cells and real-time polymerase chain reaction analysis of microtubule-associated protein 2 (MAP2) mRNA. Our results showed that the best growth was achieved by culturing mESCs for 12 d in N2B27 medium without bFGF or ascorbic acid. Lead (II) acetate and aroclor 1254 were used to test the usefulness of the new endpoint. When we used the known ID50 values for lead (II) acetate in the EST model, it was classified as non-embryotoxic; however, when we used the new ID50 values that we determined in this study, it was classified as weakly embryotoxic. Aroclor 1254 and penicillin G were also classified as weakly embryotoxic and non-embryotoxic compounds, respectively, when cardiac and neuronal differentiation ID50 values were used. Therefore, our new surrogate endpoint for developmental neurotoxicity is not only sensitive and specific but also transferable among laboratories.

Original languageEnglish
Pages (from-to)118-130
Number of pages13
JournalToxicology Mechanisms and Methods
Volume22
Issue number2
DOIs
Publication statusPublished - 2012 Feb 1

Fingerprint

Embryonic Stem Cells
Stem cells
Chlorodiphenyl (54% Chlorine)
Fibroblast Growth Factor 2
Biomarkers
Acetates
Microtubule-Associated Proteins
Penicillin G
Tubulin
Growth
Flow cytometry
Ascorbic Acid
Polymerase chain reaction
Real-Time Polymerase Chain Reaction
Flow Cytometry
Cell culture
Sensitivity and Specificity
Messenger RNA
Cells
Mouse Embryonic Stem Cells

Keywords

  • Aroclor 1254
  • Developmental neurotoxicity
  • Embryonic stem cell test
  • In vitro toxicity test
  • Lead (II) acetate
  • Mouse embryonic stem cell

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity. / Baek, Dae Hyun; An, Su Yeon; Park, Jae Hyun; Choi, Youngju; Park, Ki Dae; Kang, Jin Wook; Choi, Kyoung Suk; Park, Sung Hee; Whang, Min Young; Han, Jiyou; Kim, Jong-Hoon; Kim, Hyung Soo; Geum, Dongho; Yoo, Tae Moo.

In: Toxicology Mechanisms and Methods, Vol. 22, No. 2, 01.02.2012, p. 118-130.

Research output: Contribution to journalArticle

Baek, DH, An, SY, Park, JH, Choi, Y, Park, KD, Kang, JW, Choi, KS, Park, SH, Whang, MY, Han, J, Kim, J-H, Kim, HS, Geum, D & Yoo, TM 2012, 'Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity', Toxicology Mechanisms and Methods, vol. 22, no. 2, pp. 118-130. https://doi.org/10.3109/15376516.2011.603394
Baek, Dae Hyun ; An, Su Yeon ; Park, Jae Hyun ; Choi, Youngju ; Park, Ki Dae ; Kang, Jin Wook ; Choi, Kyoung Suk ; Park, Sung Hee ; Whang, Min Young ; Han, Jiyou ; Kim, Jong-Hoon ; Kim, Hyung Soo ; Geum, Dongho ; Yoo, Tae Moo. / Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity. In: Toxicology Mechanisms and Methods. 2012 ; Vol. 22, No. 2. pp. 118-130.
@article{d8b3cdf59c8d4d3ab40cd404bb65929f,
title = "Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity",
abstract = "We developed and analyzed a new surrogate endpoint of the mouse embryonic stem cell test (EST) for developmental neurotoxicity. To determine the sensitivity, specificity, and transferability of the new endpoint, a pre-validation team from three independent laboratories optimized and standardized the protocol for neuronal differentiation of mouse embryonic stem cells (mESCs) by measuring the neuronal differentiation rates of mESCs under different culture conditions, such as the presence or absence of basic fibroblast growth factor (bFGF) in the growth media and varying lengths of culture. In addition, a component ratio of neuronal cells was measured by using flow cytometry analysis of β-III tubulin (Tuj1)-positive cells and real-time polymerase chain reaction analysis of microtubule-associated protein 2 (MAP2) mRNA. Our results showed that the best growth was achieved by culturing mESCs for 12 d in N2B27 medium without bFGF or ascorbic acid. Lead (II) acetate and aroclor 1254 were used to test the usefulness of the new endpoint. When we used the known ID50 values for lead (II) acetate in the EST model, it was classified as non-embryotoxic; however, when we used the new ID50 values that we determined in this study, it was classified as weakly embryotoxic. Aroclor 1254 and penicillin G were also classified as weakly embryotoxic and non-embryotoxic compounds, respectively, when cardiac and neuronal differentiation ID50 values were used. Therefore, our new surrogate endpoint for developmental neurotoxicity is not only sensitive and specific but also transferable among laboratories.",
keywords = "Aroclor 1254, Developmental neurotoxicity, Embryonic stem cell test, In vitro toxicity test, Lead (II) acetate, Mouse embryonic stem cell",
author = "Baek, {Dae Hyun} and An, {Su Yeon} and Park, {Jae Hyun} and Youngju Choi and Park, {Ki Dae} and Kang, {Jin Wook} and Choi, {Kyoung Suk} and Park, {Sung Hee} and Whang, {Min Young} and Jiyou Han and Jong-Hoon Kim and Kim, {Hyung Soo} and Dongho Geum and Yoo, {Tae Moo}",
year = "2012",
month = "2",
day = "1",
doi = "10.3109/15376516.2011.603394",
language = "English",
volume = "22",
pages = "118--130",
journal = "Toxicology Mechanisms and Methods",
issn = "1537-6516",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity

AU - Baek, Dae Hyun

AU - An, Su Yeon

AU - Park, Jae Hyun

AU - Choi, Youngju

AU - Park, Ki Dae

AU - Kang, Jin Wook

AU - Choi, Kyoung Suk

AU - Park, Sung Hee

AU - Whang, Min Young

AU - Han, Jiyou

AU - Kim, Jong-Hoon

AU - Kim, Hyung Soo

AU - Geum, Dongho

AU - Yoo, Tae Moo

PY - 2012/2/1

Y1 - 2012/2/1

N2 - We developed and analyzed a new surrogate endpoint of the mouse embryonic stem cell test (EST) for developmental neurotoxicity. To determine the sensitivity, specificity, and transferability of the new endpoint, a pre-validation team from three independent laboratories optimized and standardized the protocol for neuronal differentiation of mouse embryonic stem cells (mESCs) by measuring the neuronal differentiation rates of mESCs under different culture conditions, such as the presence or absence of basic fibroblast growth factor (bFGF) in the growth media and varying lengths of culture. In addition, a component ratio of neuronal cells was measured by using flow cytometry analysis of β-III tubulin (Tuj1)-positive cells and real-time polymerase chain reaction analysis of microtubule-associated protein 2 (MAP2) mRNA. Our results showed that the best growth was achieved by culturing mESCs for 12 d in N2B27 medium without bFGF or ascorbic acid. Lead (II) acetate and aroclor 1254 were used to test the usefulness of the new endpoint. When we used the known ID50 values for lead (II) acetate in the EST model, it was classified as non-embryotoxic; however, when we used the new ID50 values that we determined in this study, it was classified as weakly embryotoxic. Aroclor 1254 and penicillin G were also classified as weakly embryotoxic and non-embryotoxic compounds, respectively, when cardiac and neuronal differentiation ID50 values were used. Therefore, our new surrogate endpoint for developmental neurotoxicity is not only sensitive and specific but also transferable among laboratories.

AB - We developed and analyzed a new surrogate endpoint of the mouse embryonic stem cell test (EST) for developmental neurotoxicity. To determine the sensitivity, specificity, and transferability of the new endpoint, a pre-validation team from three independent laboratories optimized and standardized the protocol for neuronal differentiation of mouse embryonic stem cells (mESCs) by measuring the neuronal differentiation rates of mESCs under different culture conditions, such as the presence or absence of basic fibroblast growth factor (bFGF) in the growth media and varying lengths of culture. In addition, a component ratio of neuronal cells was measured by using flow cytometry analysis of β-III tubulin (Tuj1)-positive cells and real-time polymerase chain reaction analysis of microtubule-associated protein 2 (MAP2) mRNA. Our results showed that the best growth was achieved by culturing mESCs for 12 d in N2B27 medium without bFGF or ascorbic acid. Lead (II) acetate and aroclor 1254 were used to test the usefulness of the new endpoint. When we used the known ID50 values for lead (II) acetate in the EST model, it was classified as non-embryotoxic; however, when we used the new ID50 values that we determined in this study, it was classified as weakly embryotoxic. Aroclor 1254 and penicillin G were also classified as weakly embryotoxic and non-embryotoxic compounds, respectively, when cardiac and neuronal differentiation ID50 values were used. Therefore, our new surrogate endpoint for developmental neurotoxicity is not only sensitive and specific but also transferable among laboratories.

KW - Aroclor 1254

KW - Developmental neurotoxicity

KW - Embryonic stem cell test

KW - In vitro toxicity test

KW - Lead (II) acetate

KW - Mouse embryonic stem cell

UR - http://www.scopus.com/inward/record.url?scp=84862950673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862950673&partnerID=8YFLogxK

U2 - 10.3109/15376516.2011.603394

DO - 10.3109/15376516.2011.603394

M3 - Article

C2 - 22082211

AN - SCOPUS:84862950673

VL - 22

SP - 118

EP - 130

JO - Toxicology Mechanisms and Methods

JF - Toxicology Mechanisms and Methods

SN - 1537-6516

IS - 2

ER -